Skip to main content
. 2020 Mar 5;128(4):892–906. doi: 10.1152/japplphysiol.00789.2019

Table 3.

Values of model parameters estimated by fitting the model to protocol 2 kinetic data from individual lungs in the absence or presence of verapamil in the perfusate

P1S1, mL/min P2S2, mL/min Kpgp, mL/min 2, mL/min k−2, min−1 Kd3 Δψm, mV CV, %
R6G 48.56 ± 1.03 0.75 ± 0.09 5.77 ± 0.50 11.25 ± 0.67 0.117 ± 0.007 0.030 ± 0.004 −117.5 ± 0.3 10.2 ± 1.1
R6G + verapamil 46.54 ± 0.35 1.07 ± 0.19 0 6.90 ± 0.45* 0.178 ± 0.023* 0.018 ± 0.003* −131.2 ± 5.8 9.3 ± 0.4

Values are means ± SE (n = 6 and 5 without and with verapamil, respectively). Kd1 (%BSA) was fixed at the value in Table 2. CV, coefficient of variation; R6G, rhodamine 6G.

*

Different from without verapamil (t test, P < 0.05).